Skip to main content
SpringerLink
Log in

Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Rhesus rotavirus (RRV) VP4 trypsin cleavage product VP5(1)*, a truncated form of VP5*, was expressed in baculovirus and found by immunoprecipitation to be antigenically similar to VP5* on the virion. Immunization of mice with VP5(1)* elicited neutralizing antibody that was found to be cross-reactive with viruses representing P genotypes 1, 3, 4, 6, 7, and 8. Baculovirus expressed trypsin cleavage products, VP8* (amino acids 1–246) and VP5(1)* (amino acids 247–474), were tested for their ability to elicit a protective response in a murine model of passive protection. These results were compared to those obtained with baculovirus expressed RRV VP4. Dams immunized with baculovirus expressed RRV VP4 gave birth to pups protected from RRV virus challenge. Neither VP5(1)* nor VP8* was as effective at generating protective immunity as full length VP4. However, antibody to VP5(1)* was more effective than antibody to VP8* at mediating protection even though the neutralizing antibody titers as measured by hemagglutination inhibition and focus reduction neutralization were similar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. De Zoysa I, Feachem RG (1985) Interventions for the control of diarrhoeal disease among young children: rotaviruses and cholera immunization. Bull World Health Organ 63: 569–583

    Google Scholar 

  2. Estes MK, Cohen J (1989) Rotavirus gene structure and function. Microbial Rev 53: 410–449

    Google Scholar 

  3. Estes MK, Graham DY, Mason BB (1981) Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol 39: 879–888

    Google Scholar 

  4. Fiore L, Greenberg HB, Mackow ER (1991) The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181: 553–563

    Google Scholar 

  5. Greenberg HB, Valdesuso J, Van Wyke K, Midthun K, Walsh M, McAuliffe V, Wyatt RG, Kalica AR, Flores J, Hoshino Y (1983) Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol 47: 267–275

    Google Scholar 

  6. Gorziglia M, Kapikian AZ (1992) Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant. J Virol 66: 4407–4412

    Google Scholar 

  7. Kalica AR, Flores J, Greenberg HB (1983) Identification of the rotaviral gene that codes for the hemagglutinin and protease-enhanced plaque formation. Virology 125: 194–205

    Google Scholar 

  8. Kapikian AZ, Chanock RM (1990) Rotaviruses. In: Fields BN, Knipe DN, Melnick JL, Chanock RM, Roizman B, Shope RE (eds) Virology, vol 2. Raven Press, New York, pp 1353–1404

    Google Scholar 

  9. Lopez S, Arias CF, Bell JR, Strauss JH, Espejo RT (1985) Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivity. Virology 144: 11–19

    Google Scholar 

  10. Mackow ER, Barnett JW, Chan H, Greenberg HB (1989) The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol 63: 1661–1668

    Google Scholar 

  11. Mackow ER, Vo PT, Broome R, Bass D, Greenberg HB (1990) Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol 64: 1698–1703

    Google Scholar 

  12. Mackow ER, Yamanaka MY, Dang MN, Greenberg HB (1990) DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci USA 87: 518–522

    Google Scholar 

  13. Matsui SM, Mackow ER, Greenberg HB (1989) Molecular determinant of rotavirus neutralization and protection. Adv Virus Res 36: 181–214

    Google Scholar 

  14. Matsui SM, Offit PA, Vo PT, Mackow ER, Benfield DA, Shaw RD, Padilla-Noriega L, Greenberg HB (1989) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol 27: 780–782

    Google Scholar 

  15. Nishikawa K, Fukuhara N, Liprandi F, Green K, Kapikian AZ, Chanock RM, Gorziglia M (1989) VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies. Virology 173: 631–637

    Google Scholar 

  16. Offit PA, Shaw RD, Greenberg HB (1986) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J Virol 58: 700–703

    Google Scholar 

  17. Pandilla-Noriega L, Fiore L, Rennels MB, Losonsky GA, Mackow ER, Greenberg HB (1992) Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus. J Clin Microbiol 30: 1392–1397

    Google Scholar 

  18. Prasad BVV, Burns JW, Marietta E, Estes MK, Chiu W (1990) Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron micoscopy. Nature 343: 476–479

    Google Scholar 

  19. Shaw RD, Stoner-Ma DL, Estes MK, Greenberg HB (1985) Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol 22: 286–291

    Google Scholar 

  20. Shaw RD, Mackow ER, Dyall-Smith ML, Lazdins I, Holmes IH, Greenberg HB (1988) Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus. J Virol 62: 3509–3512

    Google Scholar 

  21. Yeager M, Dryden KA, Olson NH, Greenberg HB, Baker TS (1990) Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol 110: 2133–2144

    Google Scholar 

Download references

Author information

Author notes

  1. S. J. Dunn

    Present address: Ingenex, Inc., 94025, Menlo Park, CA, USA

Authors and Affiliations

  1. Division of Gastroenterology, Stanford University School of Medicine, Stanford, California, USA

    S. J. Dunn, R. L. Werner, T. L. Cross & H. B. Greenberg

  2. Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy

    L. Fiore

  3. Palo Alto Veterans Affairs Medical Centre, Palo Alto, California, USA

    R. L. Broome & H. B. Greenberg

  4. Department of Ultrastructure, Istituto Superiore di Sanita, Rome, Italy

    F. M. Ruggeri

Authors
  1. S. J. Dunn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Fiore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. L. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. L. Cross
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. L. Broome
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. M. Ruggeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. B. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunn, S.J., Fiore, L., Werner, R.L. et al. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus. Archives of Virology 140, 1969–1978 (1995). https://doi.org/10.1007/BF01322686

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01322686

Keywords

Search

Navigation